ISD Immunotech
ISD Immunotech is developing a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients.
Aarhus, Denmarkwww.isd-immunotech.com ↗
Total raised
€0
€0
Funding rounds
1
Investors
2
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood11
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-04 | Other | — | EIR Ventures,Novo Seeds | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce